Mjalli; Adnan M.M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Mjalli; Adnan M.M..The latest application filed is for "substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof".

Company Profile

11.87.111

Mjalli; Adnan M.M. - Oak Ridge NC
Mjalli; Adnan M. M. - Jamestown NC
Mjalli, Adnan M. M. - Vista CA
Mjalli; Adnan M. M. - Louisville KY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof App 20220169641 - Mjalli; Adnan M.M. ; et al.	2022-06-02
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof Grant 11,130,753 - Mjalli , et al. September 28, 2	2021-09-28
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof Grant 10,889,580 - Mjalli , et al. January 12, 2	2021-01-12
Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof App 20210002268 - Mjalli; Adnan M.M. ; et al.	2021-01-07
Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof App 20200148673 - Mjalli; Adnan M.M. ; et al.	2020-05-14
Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors Grant 10,568,888 - Mjalli , et al. Feb	2020-02-25
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof Grant 10,570,126 - Mjalli , et al. Feb	2020-02-25
Tricyclic Compounds As Modulators Of Tnf-alpha Synthesis And As Pde4 Inhibitors App 20190336506 - Mjalli; Adnan M. M. ; et al.	2019-11-07
Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors Grant 10,391,097 - Mjalli , et al. A	2019-08-27
Compositions comprising metformin and a glucokinase activator Grant 10,363,244 - Mjalli , et al.	2019-07-30
Piperidine derivative and methods of use thereof Grant 10,364,233 - Mjalli , et al.	2019-07-30
Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof App 20190194181 - Mjalli; Adnan M.M. ; et al.	2019-06-27
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof Grant 10,287,284 - Mjalli , et al.	2019-05-14
Tricyclic Compounds As Modulators Of Tnf-alpha Synthesis And As Pde4 Inhibitors App 20180360839 - Mjalli; Adnan M. M. ; et al.	2018-12-20
Piperidine Derivative and Methods of Use Thereof App 20180362505 - Mjalli; Adnan M.M. ; et al.	2018-12-20
Compositions Comprising Metformin and A Glucokinase Activator App 20180344706 - Mjalli; Adnan M.M. ; et al.	2018-12-06
Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof App 20180291015 - Mjalli; Adnan M.M. ; et al.	2018-10-11
Tricyclic compounds as modulators of TNF-.alpha. synthesis and as PDE4 inhibitors Grant 10,085,990 - Mjalli , et al. October 2, 2	2018-10-02
Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator Grant 10,064,846 - Mjalli , et al. September 4, 2	2018-09-04
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof Grant 10,030,011 - Mjalli , et al. July 24, 2	2018-07-24
Tricyclic Compounds As Modulators Of Tnf-alpha Synthesis And As Pde4 Inhibitors App 20180071297 - Mjalli; Adnan M.M. ; et al.	2018-03-15
Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator Grant 9,855,251 - Mjalli , et al. January 2, 2	2018-01-02
Use of Metformin in Combination with a Glucokinase Activator and Compositions Comprising Metformin and a Glucokinase Activator App 20170354647 - Mjalli; Adnan M.M. ; et al.	2017-12-14
Tricyclic compounds as modulators of TNF-.alpha. synthesis and as PDE4 inhibitors Grant 9,833,457 - Mjalli , et al. December 5, 2	2017-12-05
Tricyclic Compounds As Modulators Of Tnf-alpha Synthesis And As Pde4 Inhibitors App 20170252343 - Mjalli; Adnan M.M. ; et al.	2017-09-07
Tricyclic compounds as modulators of TNF-.alpha. synthesis and as PDE4 inhibitors Grant 9,687,489 - Mjalli , et al. June 27, 2	2017-06-27
Tricyclic Compounds As Modulators Of Tnf-alpha Synthesis And As Pde4 Inhibitors App 20160296526 - Mjalli; Adnan M.M. ; et al.	2016-10-13
Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors Grant 9,393,245 - Mjalli , et al. July 19, 2	2016-07-19
Use of Metformin in Combination with a Glucokinase Activator and Compositions Comprising Metformin and a Glucokinase Activator App 20160184277 - Mjalli; Adnan M.M. ; et al.	2016-06-30
Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator Grant 9,359,313 - Mjalli , et al. June 7, 2	2016-06-07
Tricyclic Compounds As Modulators Of Tnf-alpha Synthesis And As Pde4 Inhibitors App 20150374700 - Mjalli; Adnan M.M. ; et al.	2015-12-31
Combinations of a GLP1R Agonist and Metformin and Use Thereof for the Treatment of Type 2 Diabetes and Other Disorders App 20150313908 - Mjalli; Adnan M.M. ; et al.	2015-11-05
Substituted azoanthracene derivatives and intermediates for preparation thereof Grant 9,175,003 - Mjalli , et al. November 3, 2	2015-11-03
Tricyclic compounds as modulators of TNF-.alpha. synthesis and as PDE4 inhibitors Grant 9,163,022 - Mjalli , et al. October 20, 2	2015-10-20
Aryl carbonyl derivatives as therapeutic agents Grant RE45,670 - Polisetti , et al. September 15, 2	2015-09-15
Oxadiazoanthracene compounds for the treatment of diabetes Grant 9,120,813 - Mjalli , et al. September 1, 2	2015-09-01
Substituted Azoanthracene Derivatives and Intermediates for Preparation Thereof App 20150148539 - Mjalli; Adnan M.M. ; et al.	2015-05-28
Oxadiazoanthracene Compounds for the Treatment of Diabetes App 20150087640 - Mjalli; Adnan M.M. ; et al.	2015-03-26
Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof Grant 8,987,295 - Mjalli , et al. March 24, 2	2015-03-24
Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors Grant 8,946,259 - Mjalli , et al. February 3, 2	2015-02-03
Oxadiazoanthracene compounds for the treatment of diabetes Grant 8,933,222 - Mjalli , et al. January 13, 2	2015-01-13
Tricyclic Compounds as Modulators of TNF-alpha Synthesis and as PDE4 Inhibitors App 20140371250 - Mjalli; Adnan M.M. ; et al.	2014-12-18
Rage fusion proteins and methods of use Grant 8,877,192 - Mjalli , et al. November 4, 2	2014-11-04
Tricyclic compounds as modulators of TNF-.alpha. synthesis and as PDE4 inhibitors Grant 8,853,226 - Mjalli , et al. October 7, 2	2014-10-07
Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof App 20140200212 - Mjalli; Adnan M.M. ; et al.	2014-07-17
Oxadiazoanthracene Compounds for the Treatment of Diabetes App 20140187769 - Mjalli; Adnan M.M. ; et al.	2014-07-03
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof Grant 8,759,535 - Mjalli , et al. June 24, 2	2014-06-24
Oxadiazoanthracene compounds for the treatment of diabetes Grant 8,703,766 - Mjalli , et al. April 22, 2	2014-04-22
Benzazole Derivatives, Compositions, and Methods of Use as Beta-Secretase Inhibitors App 20140066477 - Mjalli; Adnan M.M. ; et al.	2014-03-06
Benzazole derivatives, compositions, and methods of use as .beta.-secretase inhibitors Grant 8,598,353 - Mjalli , et al. December 3, 2	2013-12-03
Oxadiazoanthracene Compounds For The Treatment Of Diabetes App 20130317015 - Mjalli; Adnan M.M. ; et al.	2013-11-28
Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use Grant 8,563,742 - Mjalli , et al. October 22, 2	2013-10-22
Oxadiazoanthracene compounds for the treatment of diabetes Grant 8,524,708 - Mjalli , et al. September 3, 2	2013-09-03
Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as .beta.-secretase inhibitors Grant 8,450,354 - Mjalli , et al. May 28, 2	2013-05-28
Substituted Azoanthracene Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof App 20130096150 - Mjalli; Adnan M.M. ; et al.	2013-04-18
Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors Grant 8,404,731 - Mjalli , et al. March 26, 2	2013-03-26
Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof Grant 8,383,644 - Mjalli , et al. February 26, 2	2013-02-26
Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors Grant 8,377,983 - Mjalli , et al. February 19, 2	2013-02-19
Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors Grant 8,350,039 - Mjalli , et al. January 8, 2	2013-01-08
Nucleic acid molecules encoding rage fusion proteins Grant 8,344,120 - Mjalli , et al. January 1, 2	2013-01-01
Tricyclic compounds as modulators of TNF-.alpha. synthesis and as PDE4 inhibitors Grant 8,329,715 - Mjalli , et al. December 11, 2	2012-12-11
Substituted Imidazole Derivatives, Compositions, and Methods of Use as PTPase Inhibitors App 20120196906 - Mjalli; Adnan M.M. ; et al.	2012-08-02
Tricyclic Compounds as Modulators of TNF-alpha Synthesis and as PDE4 Inhibitors App 20120172381 - Mjalli; Adnan M. M. ; et al.	2012-07-05
Rage Fusion Proteins And Methods Of Use App 20120171202 - MJALLI; ADNAN M.M. ; et al.	2012-07-05
Substituted Isoquinoline Derivatives, Pharmaceutical Compositions, And Methods Of Use As Beta-secretase Inhibitors App 20120101125 - Mjalli; Adnan M. M. ; et al.	2012-04-26
Substituted Imidazo[1,2-a]pyridine Derivatives, Pharmaceutical Compositions, And Methods Of Use As Beta-secretase Inhibitors App 20120101093 - Mjalli; Adnan M. M. ; et al.	2012-04-26
Azole Derivatives And Fused Bicyclic Azole Derivatives As Therapeutic Agents App 20120088778 - Mjalli; Adnan M.M. ; et al.	2012-04-12
N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes Grant 8,148,413 - Lau , et al. April 3, 2	2012-04-03
Use Of Metformin In Combination With A Glucokinase Activator And Compositions Comprising Metformin And A Glucokinase Activator App 20110313007 - Mjalli; Adnan M.M. ; et al.	2011-12-22
Aryl Carbonyl Derivatives As Therapeutic Agents App 20110301158 - Polisetti; Dharma Rao ; et al.	2011-12-08
Aryl carbonyl derivatives as therapeutic agents Grant 8,063,081 - Polisetti , et al. November 22, 2	2011-11-22
Rage Fusion Proteins, Formulations And Methods Of Use Thereof App 20110282035 - Mjalli; Adnan M.M. ; et al.	2011-11-17
Rage Fusion Proteins And Methods Of Use App 20110244516 - Mjalli; Adnan M.M. ; et al.	2011-10-06
Substituted Imidazo[1,2-b]pyridazine Derivatives, Pharmaceutical Compositions, And Methods Of Use As Beta-secretase Inhibitors App 20110237570 - Mjalli; Adnan M.M. ; et al.	2011-09-29
Substituted Fused Imidazole Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof App 20110201604 - Mjalli; Adnan M. M. ; et al.	2011-08-18
RAGE fusion proteins, formulations, and methods of use thereof Grant 7,981,424 - Mjalli , et al. July 19, 2	2011-07-19
Rage fusion proteins Grant 7,981,423 - Mjalli , et al. July 19, 2	2011-07-19
Substituted Azoanthracene Derivatives, Pharmaceutical Compositions, And Methods Of Use Thereof App 20110160198 - Mjalli; Adnan M.M. ; et al.	2011-06-30
Tricyclic Compounds as Modulators of TNF-alpha Synthesis and as PDE4 Inhibitors App 20110160234 - Mjalli; Adnan M.M. ; et al.	2011-06-30
Tricyclic compounds as modulators of TNF-.alpha. synthesis Grant 7,964,608 - Mjalli , et al. June 21, 2	2011-06-21
Rage Fusion Proteins And Methods Of Use App 20110124102 - Mjalli; Adnan M.M. ; et al.	2011-05-26
Immunoglobulin Fusion Proteins and Methods of Making App 20110110945 - Mjalli; Adnan M.M. ; et al.	2011-05-12
Substituted Azole Derivatives, Compositions, and Methods of Use App 20110092553 - Mjalli; Adnan M.M. ; et al.	2011-04-21
N-heteroaryl Indole Carboxamides And Analogues Thereof, For Use As Glucokinase Activators In The Treatment Of Diabetes App 20110082144 - Lau; Jesper F. ; et al.	2011-04-07
Substituted Azole Derivatives as Therapeutic Agents App 20110077399 - Mjalli; Adnan M. M. ; et al.	2011-03-31
Benzazole Derivatives, Compositions, and Methods of Use as B-Secretase Inhibitors App 20110065713 - Mjalli; Adnan M.M. ; et al.	2011-03-17
Oxadiazoanthracene compounds for the treatment of diabetes Grant 7,906,507 - Mjalli , et al. March 15, 2	2011-03-15
Rage fusion proteins Grant 7,901,688 - Mjalli , et al. March 8, 2	2011-03-08
Aryl carbonyl derivatives as therapeutic agents Grant 7,897,628 - Polisetti , et al. March 1, 2	2011-03-01
Benzazole derivatives, compositions, and methods of use as .beta.-secretase inhibitors Grant 7,893,267 - Mjalli , et al. February 22, 2	2011-02-22
Probes, Systems, and Methods for Drug Discovery App 20110039714 - Mjalli; Adnan M. M. ; et al.	2011-02-17
Oxadiazoanthracene Compounds For The Treatment Of Diabetes App 20110039837 - Mjalli; Adnan M.M. ; et al.	2011-02-17
Oxadiazoanthracene Compounds For The Treatment Of Diabetes App 20100324033 - Mjalli; Adnan M.M. ; et al.	2010-12-23
Carboxamide Derivatives As Therapeutic Agents App 20100286197 - Mjalli; Adnan M.M. ; et al.	2010-11-11
Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors Grant 7,820,821 - Mjalli , et al. October 26, 2	2010-10-26
Substituted heteroaryl derivatives, compositions, and methods of use Grant 7,820,704 - Mjalli , et al. October 26, 2	2010-10-26
N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes Grant 7,812,043 - Lau , et al. October 12, 2	2010-10-12
Azole derivatives and fused bicyclic azole derivatives as therapeutic agents App 20100256119 - Mjalli; Adnan M.M. ; et al.	2010-10-07
Oxadiazoanthracene compounds for the treatment of diabetes Grant 7,790,714 - Mjalli , et al. September 7, 2	2010-09-07
Carboxamide derivatives as therapeutic agents Grant 7,776,919 - Mjalli , et al. August 17, 2	2010-08-17
Oxadiazoanthracene Compounds For The Treatment Of Diabetes App 20100197677 - Mjalli; Adnan M.M. ; et al.	2010-08-05
Tricyclic Compounds As Modulators of TNF-alpha Synthesis App 20100190808 - Mjalli; Adnan M. M. ; et al.	2010-07-29
Benzazole Derivatives, Compositions, And Methods Of Use As Aurora Kinase Inhibitors App 20100152170 - Mjalli; Adnan M.M. ; et al.	2010-06-17
Azole derivatives and fused bicyclic azole derivatives as therapeutic agents Grant 7,737,285 - Mjalli , et al. June 15, 2	2010-06-15
Oxadiazoanthracene compounds for the treatment of diabetes Grant 7,727,983 - Mjalli , et al. June 1, 2	2010-06-01
Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors Grant 7,723,369 - Mjalli , et al. May 25, 2	2010-05-25
Azole derivatives and fused bicyclic azole derivatives as therapeutic agents Grant 7,714,013 - Mjalli , et al. May 11, 2	2010-05-11
Substituted Imidazole Derivatives, Compositions, and Methods of Use as PtPase Inhibitors App 20100113331 - MJALLI; ADNAN M. M. ; et al.	2010-05-06
Substituted Aminothiazole Derivatives, Pharmaceutical Compositions, And Methods Of Use App 20100056587 - Mjalli; Adnan M. M. ; et al.	2010-03-04
Benzazole Derivatives, Compositions, and Methods of Use as Beta-Secretase Inhibitors App 20090326006 - Mjalli; Adnan M.M. ; et al.	2009-12-31
Oxadiazoanthracene Compounds For The Treatment Of Diabetes App 20090306063 - Mjalli; Adnan M.M. ; et al.	2009-12-10
Bissulfonamide Compounds As Agonists Of GalR1, Compositions, And Methods Of Use App 20090247536 - Mjalli; Adnan M.M. ; et al.	2009-10-01
Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use Grant 7,582,673 - Mjalli , et al. September 1, 2	2009-09-01
Aryl and heteroaryl compounds, compositions, and methods of use Grant 7,544,699 - Mjalli , et al. June 9, 2	2009-06-09
Aryl carbonyl derivatives as therapeutic agents Grant 7,541,373 - Polisetti , et al. June 2, 2	2009-06-02
Aryl and Heteroaryl Compounds, Compositions, Methods of Use App 20090124654 - Mjalli; Adnan M.M. ; et al.	2009-05-14
Aryl and heteroaryl compounds, compositions and methods of use Grant 7,501,538 - Mjalli , et al. March 10, 2	2009-03-10
Rage Fusion Proteins and Methods of Use App 20090060925 - Mjalli; Adnan M.M. ; et al.	2009-03-05
Rage Antagonists As Agents To Reverse Amyloidosis And Diseases Associated Therewith App 20090035302 - Mjalli; Adnan M. M. ; et al.	2009-02-05
Rage Fusion Proteins And Methods Of Use App 20090004190 - Mjalli; Adnan M.M. ; et al.	2009-01-01
Aryl and heteroaryl compounds, compositions, and methods of use Grant 7,459,472 - Mjalli , et al. December 2, 2	2008-12-02
Carboxamide derivatives as therapeutic agents Grant 7,423,177 - Mjalli , et al. September 9, 2	2008-09-09
Immunoglobulin fusion proteins and methods of making App 20080199467 - Mjalli; Adnan M. M. ; et al.	2008-08-21
Aryl carbonyl derivatives as therapeutic agents Grant 7,384,967 - Polisetti , et al. June 10, 2	2008-06-10
Carboxamide Derivatives as Therapeutic Agents App 20080119512 - Mjalli; Adnan M.M. ; et al.	2008-05-22
Aryl carbonyl derivatives as therapeutic agents App 20080119455 - Polisetti; Dharma Rao ; et al.	2008-05-22
Benzimidazole Derivatives as Therapeutic Agents App 20080119534 - Mjalli; Adnan M.M. ; et al.	2008-05-22
Aryl carbonyl derivatives as therapeutic agents App 20080119454 - Polisetti; Dharma Rao ; et al.	2008-05-22
Azole derivatives and fused bicyclic azole derivatives as therapeutic agents Grant 7,361,678 - Mjalli , et al. April 22, 2	2008-04-22
Rage Fusion Proteins And Method Of Use App 20080075733 - Mjalli; Adnan M.M. ; et al.	2008-03-27
RAGE fusion proteins, formulations, and methods of use thereof App 20080045455 - Mjalli; Adnan M.M. ; et al.	2008-02-21
Benzimidazole derivatives as therapeutic agents Grant 7,329,684 - Mjalli , et al. February 12, 2	2008-02-12
Aryl and heteroaryl compounds, compositions, and methods of use App 20070254916 - Mjalli; Adnan M.M. ; et al.	2007-11-01
Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents App 20070219239 - Mjalli; Adnan M.M. ; et al.	2007-09-20
Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors App 20070219235 - Mjalli; Adnan M.M. ; et al.	2007-09-20
Azole derivatives and fused bicyclic azole derivatives as therapeutic agents App 20070213347 - Mjalli; Adnan M. M. ; et al.	2007-09-13
Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors App 20070191385 - Mjalli; Adnan M.M. ; et al.	2007-08-16
Fluorescence polarization assay App 20070154954 - Mjalli; Adnan M.M. ; et al.	2007-07-05
Ligands for 17i as modulators of orthopox viruses and methods for discovery thereof App 20070112523 - Mjalli; Adnan M. M. ; et al.	2007-05-17
Aryl and heteroaryl compounds, compositions, and methods of use Grant 7,208,601 - Mjalli , et al. April 24, 2	2007-04-24
N-heteroaryl indole carboxamides and analogues thereof, for use as glcokinase activators in the treatment of diabetes App 20070027140 - Lau; Jesper F. ; et al.	2007-02-01
Azole derivatives and fused bicyclic azole derivatives as therapeutic agents App 20070021386 - Mjalli; Adnan M.M. ; et al.	2007-01-25
Aryl and heteroaryl compounds and methods to modulate coagulation App 20060276518 - Mjalli; Adnan M. M. ; et al.	2006-12-07
Aryl and heteroaryl compounds and methods to modulate coagulation Grant 7,122,580 - Mjalli , et al. October 17, 2	2006-10-17
Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors App 20060223849 - Mjalli; Adnan M.M. ; et al.	2006-10-05
Method for the synthesis of compounds of formula I and their uses thereof App 20060189578 - Mjalli; Adnan M.M. ; et al.	2006-08-24
Aryl carbonyl derivatives as therapeutic agents App 20060183783 - Polisetti; Dharma Rao ; et al.	2006-08-17
Benzimidazole derivatives as therapeutic agents Grant 7,087,632 - Mjalli , et al. August 8, 2	2006-08-08
Method for the sysnthesis of compounds of formula I and their uses thereof App 20060148760 - Mjalli; Adnan M.M. ; et al.	2006-07-06
Method for the synthesis of compounds of formula I and their uses thereof Grant 7,067,554 - Mjalli , et al. June 27, 2	2006-06-27
Bis-heteroaryl alkanes as therapeutic agents App 20060128784 - Mjalli; Adnan M.M. ; et al.	2006-06-15
Bissulfonamide compounds as agonists of GalR1, compositions, and methods of use App 20060106089 - Mjalli; Adnan M.M. ; et al.	2006-05-18
RAGE fusion proteins and methods of use App 20060078562 - Mjalli; Adnan M.M. ; et al.	2006-04-13
Bis-heteroaryl alkanes as therapeutic agents Grant 7,022,730 - Mjalli , et al. April 4, 2	2006-04-04
Rage fusion proteins and methods of use App 20060030527 - Mjalli; Adnan M.M. ; et al.	2006-02-09
Benzimidazole derivatives as therapeutic agents App 20060025464 - Mjalli; Adnan M.M. ; et al.	2006-02-02
Substituted heteroaryl derivatives, compositions, and methods of use App 20050261294 - Mjalli, Adnan M.M. ; et al.	2005-11-24
Substituted azole derivatives, compositions, and methods of use App 20050187277 - Mjalli, Adnan M.M. ; et al.	2005-08-25
Heteroaryl-fused nitrogen heterocycles as therapeutic agents Grant 6,933,303 - Mjalli , et al. August 23, 2	2005-08-23
Multicomponent synthesis of amino acids and derivatives thereof Grant 6,930,200 - Mjalli August 16, 2	2005-08-16
Aryl and heteroaryl compounds, compositions, methods of use App 20050171148 - Mjalli, Adnan M.M. ; et al.	2005-08-04
Heteroaryl - fused nitrogen heterocycles as therapeutic agents App 20050096335 - Mjalli, Adnan M. M. ; et al.	2005-05-05
Aryl and heteroaryl compounds, compositions, and methods of use App 20050059705 - Mjalli, Adnan M.M. ; et al.	2005-03-17
Aryl and heteroaryl compounds, compositions, and methods of use App 20050059713 - Mjalli, Adnan M.M. ; et al.	2005-03-17
Aryl and heteroaryl compounds, compositions and methods of use App 20050049310 - Mjalli, Adnan M.M. ; et al.	2005-03-03
Rage antagonists as agents to reverse amyloidosis and diseases associated therewith App 20050026811 - Mjalli, Adnan M. M. ; et al.	2005-02-03
Substituted azole derivatives as therapeutic agents App 20040192743 - Mjalli, Adnan M.M. ; et al.	2004-09-30
Substituted azole derivatives as therapeutic agents App 20040186151 - Mjalli, Adnan M.M. ; et al.	2004-09-23
Aryl carbonyl derivatives as therapeutic agents App 20040122235 - Polisetti, Dharma Rao ; et al.	2004-06-24
Aryl and heteroaryl compounds and methods to modulate coagulation App 20040110832 - Mjalli, Adnan M.M. ; et al.	2004-06-10
Method for the synthesis of compounds of formula I and their uses thereof App 20040097407 - Mjalli, Adnan M.M. ; et al.	2004-05-20
Azole derivatives and fused bicyclic azole derivatives as therapeutic agents App 20040082542 - Mjalli, Adnan M.M. ; et al.	2004-04-29
Method for the synthesis of compounds of formula 1 and derivatives thereof App 20040059149 - Mjalli, Adnan M.M.	2004-03-25
Heteroaryl - fused nitrogen heterocycles as therapeutic agents App 20040014778 - Mjalli, Adnan M.M. ; et al.	2004-01-22
Amide derivatives as therapeutic agents App 20030171411 - Kodra, Janos Tibor ; et al.	2003-09-11
Method for the synthesis of compounds of formula I and their uses thereof Grant 6,613,801 - Mjalli , et al. September 2, 2	2003-09-02
Bis-Heteroaryl alkanes as therapeutic agents App 20030130335 - Mjalli, Adnan M. M. ; et al.	2003-07-10
Probes, systems, and methods for drug discovery App 20030125315 - Mjalli, Adnan M. M. ; et al.	2003-07-03
Method for synthesis of .alpha.-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives Grant 6,583,318 - Campian , et al. June 24, 2	2003-06-24
Method for synthesis of alpha-sulfonamido amide, carboxylic acid and hydroxamic acid derivatives App 20030013910 - Campian, Eugene ; et al.	2003-01-16
Carboxamide derivatives as therapeutic agents App 20020193432 - Mjalli, Adnan M. M. ; et al.	2002-12-19
Modulators of proteins with phosphotyrosine recognition units App 20020183518 - Mjalli, Adnan M. M. ; et al.	2002-12-05
Heterocycle derivatives as PPAR-gamma agonists App 20020082263 - Lou, Boliang ; et al.	2002-06-27
Method for the synthesis of compounds of formula I and their uses thereof App 20020006957 - Mjalli, Adnan M.M. ; et al.	2002-01-17
Amino-ketone solid support templates Grant 6,117,940 - Mjalli September 12, 2	2000-09-12
Imidazole derivatives as MDR modulators Grant 5,840,721 - Mjalli , et al. November 24, 1	1998-11-24
Nitric oxide synthase (NOS) inhibitors Grant 5,723,451 - Mjalli , et al. March 3, 1	1998-03-03

Company Registrations

SEC

0001275596

MJALLI ADNAN M M